Omada Health, Inc. Payments to Develop Software
Omada Health, Inc. (OMDA) reported Payments to Develop Software of $3.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToDevelopSoftware · last filed 2026-08-07
- Omada Health, Inc. payments to develop software for the quarter ending 2026-06-30 was $1.52M, a 55.06% increase year-over-year.
- Omada Health, Inc. payments to develop software for the quarter ending 2026-03-31 was $1.48M, a 58.35% increase year-over-year.
- Omada Health, Inc. payments to develop software for the quarter ending 2025-12-31 was $1.15M, a 46.11% increase year-over-year.
- Omada Health, Inc. payments to develop software for the quarter ending 2025-09-30 was $1.45M, a 46.17% increase year-over-year.
- Omada Health, Inc. payments to develop software for fiscal 2025 was $4.51M, a 38.05% increase from fiscal 2024.
- Omada Health, Inc. payments to develop software for fiscal 2024 was $3.27M, a 30.42% increase from fiscal 2023.
- Omada Health, Inc. payments to develop software for fiscal 2023 was $2.50M.
| Period end | Payments to Develop Software 3 month | Payments to Develop Software 6 month | Payments to Develop Software 9 month | Payments to Develop Software 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.00M 10-Q · filed 2026-08-07 | $4.14M derived: sum of 3 quarters · filed 2026-08-07 | $5.59M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.48M 10-Q · filed 2026-05-08 | $2.63M derived: sum of 2 quarters · filed 2026-05-08 | $4.08M derived: sum of 3 quarters · filed 2026-05-08 | $5.05M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.60M derived: sum of 2 quarters · filed 2026-03-06 | $3.58M derived: sum of 3 quarters · filed 2026-08-07 | $4.51M 10-K · filed 2026-03-06 |
| 2025-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.43M derived: sum of 2 quarters · filed 2026-08-07 | $3.36M 10-Q · filed 2025-11-07 | $4.15M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $979.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.91M 10-Q · filed 2026-08-07 | $2.70M derived: sum of 3 quarters · filed 2026-08-07 | $3.69M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $934.00K 10-Q · filed 2026-05-08 | $1.72M derived: sum of 2 quarters · filed 2026-05-08 | $2.71M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $785.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $1.78M derived: sum of 2 quarters · filed 2026-03-06 | $3.27M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $992.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.48M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $1.49M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $2.50M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |